YOLFTbeta
Cibus Global LLC

Cibus Global LLC

CBUS · NASDAQ · Healthcare / Biotechnology

1.13USD+0.04 (+3.67%)

Price History

Full chart

Market Stats

Previous Close1.09
Open1.08
Day Range1.02 – 1.14
52-Week Range1.09 – 4.19
Volume148.18K
Market Cap116.17M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.51
Dividend Yield0.00%
Beta1.59
50-Day Avg1.72
200-Day Avg1.89

About

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Craig Wichner
  • Employees118
  • Headquarters6455 Nancy Ridge Drive, San Diego, CA, United States, 92121, USA
  • Websitehttps://www.cibus.com

Leadership

  • Mr. Craig WichnerChief Executive Officer · b. 1970
  • Dr. Peter R. Beetham B.Sc., Ph.D.Co-Founder, President & COO · b. 1963
  • Dr. Gregory F. Gocal Ph.D.Co-Founder, Chief Scientific Officer & Executive VP · b. 1969
  • Mr. Rory Balfour Riggs M.B.A.Co-Founder & Director · b. 1953
  • Mr. Jason Stokes Esq., J.D.Chief Administrative Officer, General Counsel & Corporate Secretary · b. 1971
  • Mr. Cornelis Broos M.Sc.Chief Financial Officer · b. 1972
  • Ms. Rosa Cheuk Kim J.D.Senior Vice President of Legal
  • Dr. Noel Sauer Ph.D.Senior Vice President of Research · b. 1967

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.27M399.00K508.00K236.00K7.30M23.85M25.99M157.00K1.82M4.26M3.64M
Growth (%)--68.63%+27.32%-53.54%+2991.53%+226.91%+8.96%-99.40%+1057.32%+134.56%-14.62%
Cost of Revenue751.00K200.00K551.00K1.08M9.28M35.13M28.56M2.00M395.00K6.86M5.92M
Gross Profit521.00K199.00K-43.00K-845.00K-1.98M-11.28M-2.57M157.00K1.42M-2.60M-2.28M
Gross Margin40.96%49.87%-8.46%-358.05%-27.19%-47.28%-9.89%100.00%78.26%-60.93%-62.76%
Operating Expense6.33M12.31M25.75M27.27M37.69M32.56M26.76M22.53M320.31M74.37M65.18M
Operating Income-5.81M-12.11M-25.79M-28.11M-39.67M-43.83M-29.33M-22.37M-318.88M-76.96M-67.46M
Operating Margin-457.08%-3034.84%-5076.57%-11913.14%-543.76%-183.77%-112.87%-14248.41%-17549.97%-1805.82%-1853.92%
EBITDA-5.48M-11.74M-25.17M-25.56M-36.52M-41.53M-25.43M-20.84M-314.58M-241.63M-90.77M
EBITDA Margin-430.90%-2941.35%-4954.33%-10830.08%-500.48%-174.13%-97.86%-13271.34%-17313.43%-5669.52%-2494.31%
Net Income-5.89M-12.09M-25.98M-27.90M-39.61M-44.84M-29.20M-16.89M-267.63M-251.39M-127.08M
Net Income Margin-462.97%-3029.07%-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.60%-14729.06%-5898.36%-3492.31%
R&D2.77M5.64M11.56M9.85M12.21M11.08M11.34M11.55M42.37M50.43M44.20M
R&D as % of Total Revenue217.45%1413.03%2274.80%4172.03%167.39%46.46%43.62%7358.60%2331.70%1183.22%1214.56%
Interest Expense261.00K5.00K1.00K1.26M1.49M1.44M1.43M75.00K18.89M34.19M35.48M
Interest Expense % of Total Revenue20.52%1.25%0.20%532.63%20.42%6.02%5.51%47.77%1039.74%802.21%975.02%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets26.00M16.62M72.17M118.79M88.10M63.33M37.19M22.42M544.41M350.07M305.05M
Total Liabilities1.74M3.50M14.69M25.39M25.59M26.45M23.06M15.19M206.12M252.24M283.22M
Total Equity24.26M13.12M57.48M93.40M62.51M36.88M14.13M7.23M338.29M97.83M21.83M
Cash24.69M5.03M56.66M93.79M58.61M17.30M13.82M3.43M32.70M14.43M9.92M
Total Debt--10.15M18.48M18.60M19.76M17.88M13.54M24.62M36.29M267.96M
Net Debt-24.69M-5.03M-46.52M-75.31M-40.01M2.46M4.05M10.12M-8.08M21.85M258.04M

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.69M-9.24M-12.79M-20.25M-31.95M-43.67M-18.81M-19.36M-46.21M-58.04M-50.59M
Investing Cash Flow-665.00K-10.42M-779.00K-1.80M-2.97M-13.48M11.20M-1.52M55.06M-808.00K-578.00K
Financing Cash Flow31.74M26.85M65.20M60.67M-330.00K15.41M3.74M9.99M20.32M40.60M46.65M
Capital Expenditure665.00K10.42M779.00K1.85M2.97M1.79M497.00K1.52M4.32M808.00K578.00K
Free Cash Flow-7.36M-19.66M-13.56M-22.10M-34.92M-45.46M-19.31M-20.88M-50.53M-58.85M-51.17M
Dividends Paid110.00K----------
FCF to OCF109.94%212.85%106.09%109.12%109.29%104.09%102.64%107.85%109.35%101.39%101.14%
Dividend Paid to FCF-1.50%----------

Earnings

Report DateAug 30, 2017Nov 13, 2017Mar 14, 2018May 7, 2018Aug 1, 2018Nov 13, 2018Mar 11, 2019May 8, 2019Aug 6, 2019Nov 6, 2019Mar 5, 2020May 7, 2020Aug 5, 2020Nov 5, 2020Mar 5, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Mar 4, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Mar 2, 2023May 2, 2023Aug 10, 2023Nov 9, 2023Mar 21, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Mar 19, 2025May 8, 2025Aug 14, 2025Nov 13, 2025Mar 18, 2026May 14, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate--7.18--13.78-10.91-14.49-12.62--13.65-15.08--16.00-14.14-15.00--11.50-9.00-9.33--8.75-7.25-7.50-5.50-3.00-1.00-1.16-1.43-1.01-0.82-0.89-0.76-0.36-0.33-0.18-0.15-0.12-0.26-0.27
EPS Actual-8.66-25.50-12.35-8.00-12.50-11.50-13.00-11.28-14.50-16.00-18.50-17.00-16.50-13.61-18.64-13.50-8.51-12.00-9.20-7.00-7.00-6.50-3.00-5.45-3.05-1.59-12.59-1.12-1.140.06-0.87-0.74-0.61-0.44-0.42-0.33-0.29-
Surprise--255.15%-41.94%-14.57%20.63%-3.01%--6.23%-6.10%--6.25%-16.69%9.27%--17.39%5.44%-28.62%-20.00%3.45%13.33%45.45%-81.67%-205.00%-37.07%-780.42%-10.89%-39.02%106.74%-14.47%-105.56%-84.85%-144.44%-178.07%-175.00%-11.54%-
Timing-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap116.17M
Enterprise Value130.01M
Trailing P/E0.00
Forward P/E0.00
Price / Sales26.72
Price / Book7.95
EPS-1.51
Book Value0.194
Revenue (TTM)4.35M
Gross Profit (TTM)4.35M
EBITDA-48.87M
Profit Margin0.00%
Operating Margin-1300.30%
Return on Equity-223.16%
Return on Assets-10.22%
Shares Outstanding76.43M
Shares Float57.24M
Beta1.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 14.33
  • Strong Buy
    2
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
29.16%
Insiders
26.10%
Retail / Other
44.74%

Top Institutional Holders

  • FMR Inc
    11.43M14.95%
  • Vanguard Capital Management, LLC
    2.12M2.77%
  • Davidson Kempner Capital Management LP
    1.53M2.00%
  • Weiss Asset Management LP
    888.12K1.16%
  • United Capital Financial Advisers Inc
    576.04K0.75%
  • Geode Capital Management, LLC
    482.91K0.63%
  • BlackRock Inc
    415.18K0.54%
  • Prescott Group Capital Management LLC
    328.16K0.43%
  • Squarepoint Ops LLC
    312.10K0.41%
  • Susquehanna International Group, LLP
    263.86K0.35%
  • Vanguard Fiduciary Trust Co
    258.15K0.34%
  • The Goldman Sachs Group Inc
    218.33K0.29%

Top Fund Holders

  • Fidelity Growth Company Fund
    3.40M4.45%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.60M2.10%
  • Fidelity Growth Company K6
    978.88K1.28%
  • Fidelity Series Growth Company
    848.63K1.11%
  • Fidelity Blue Chip Growth
    713.36K0.93%
  • Fidelity Extended Market Index
    257.78K0.34%
  • iShares Micro-Cap ETF
    202.88K0.27%
  • Abante Quant Value FI
    182.46K0.24%

Stock Splits

  • Jun 1, 20231:5
  • Apr 25, 20231:10